We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MPH market cap is 11.06M. The company's latest EPS is CAD -0.0883 and P/E is -13.36.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 20.17M | 11.61M | 21.74M | 23.07M | 21.69M |
| Operating Income | -18.19M | -8.11M | -2.09M | 1.19M | -854k |
| Net Income | -19.79M | -6.85M | -727k | 1.37M | -922k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 42.28M | 34.05M | 28.41M | 29.9M | 28.06M |
| Total Liabilities | 15.34M | 14.91M | 10M | 8.89M | 8.16M |
| Total Equity | 26.94M | 19.15M | 18.41M | 21.01M | 19.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -14.64M | -2.24M | 3.99M | 1.83M | 2.08M |
| Investing | 34.28M | -7.24M | -2.69M | -310k | -270k |
| Financing | -30.26M | -766k | -316k | -355k | -297k |
| Market Cap | 11.06M |
| Price to Earnings Ratio | -13.36 |
| Price to Sales Ratio | 0.57 |
| Price to Cash Ratio | 1.93 |
| Price to Book Ratio | 0.62 |
| Dividend Yield | - |
| Shares Outstanding | 10.44M |
| Average Volume (1 week) | 1.65k |
| Average Volume (1 Month) | 3.93k |
| 52 Week Change | -4.50% |
| 52 Week High | 1.80 |
| 52 Week Low | 0.99 |
| Spread (Intraday) | 0.04 (3.64%) |
| Company Name | Medicure Inc |
| Address |
2-1250 waverley street winnipeg, manitoba R3T 6C6 |
| Website | https://www.medicure.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
